水解胶原蛋白治疗骨关节炎患者血清生物标志物的变化:一项前瞻性随机研究的结果

Journal of arthritis Pub Date : 2016-10-03 DOI:10.4172/2167-7921.1000219

K. Flechsenhar, T. McAlindon

{"title":"水解胶原蛋白治疗骨关节炎患者血清生物标志物的变化:一项前瞻性随机研究的结果","authors":"K. Flechsenhar, T. McAlindon","doi":"10.4172/2167-7921.1000219","DOIUrl":null,"url":null,"abstract":"Klaus Flechsenhar1 and Timothy McAlindon2 1Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany 2Tufts Medical Center, Chief, Division of Rheumatology, Boston, USA *Corresponding author: Klaus Flechsenhar, MD, Sanofi-Aventis Deutschland GmbH, Therapeutic Area Immunology, Cytokine Modulation, Industriepark Hoechst, Building H821, Room 525, D-65926 Frankfurt am Main Germany, Tel: +49 69 305 17403; Fax: +49 69 305 47223; E-mail: Klaus.Flechsenhar@sanofi.com","PeriodicalId":91304,"journal":{"name":"Journal of arthritis","volume":"5 1","pages":"1-2"},"PeriodicalIF":0.0000,"publicationDate":"2016-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4172/2167-7921.1000219","citationCount":"3","resultStr":"{\"title\":\"Change in Serum Biomarkers in Patients with Osteoarthritis treated with Collagen Hydrolysate: Results of a Prospective Randomized Study\",\"authors\":\"K. Flechsenhar, T. McAlindon\",\"doi\":\"10.4172/2167-7921.1000219\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Klaus Flechsenhar1 and Timothy McAlindon2 1Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany 2Tufts Medical Center, Chief, Division of Rheumatology, Boston, USA *Corresponding author: Klaus Flechsenhar, MD, Sanofi-Aventis Deutschland GmbH, Therapeutic Area Immunology, Cytokine Modulation, Industriepark Hoechst, Building H821, Room 525, D-65926 Frankfurt am Main Germany, Tel: +49 69 305 17403; Fax: +49 69 305 47223; E-mail: Klaus.Flechsenhar@sanofi.com\",\"PeriodicalId\":91304,\"journal\":{\"name\":\"Journal of arthritis\",\"volume\":\"5 1\",\"pages\":\"1-2\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-10-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.4172/2167-7921.1000219\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of arthritis\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4172/2167-7921.1000219\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of arthritis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2167-7921.1000219","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 3

摘要

通讯作者:Klaus Flechsenhar，医学博士，赛诺菲-安万特德国有限公司，德国法兰克福2塔夫茨医疗中心，风湿病科主任，美国波士顿*通讯作者:Klaus Flechsenhar，医学博士，赛诺菲-安万特德国有限公司，治疗领域免疫学，细胞因子调节，赫斯特工业园区，H821楼，525室，D-65926德国法兰克福，电话:+49 69 305 17403;传真:+49 69 305 47223;电子邮件:Klaus.Flechsenhar@sanofi.com

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Change in Serum Biomarkers in Patients with Osteoarthritis treated with Collagen Hydrolysate: Results of a Prospective Randomized Study

Klaus Flechsenhar1 and Timothy McAlindon2 1Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany 2Tufts Medical Center, Chief, Division of Rheumatology, Boston, USA *Corresponding author: Klaus Flechsenhar, MD, Sanofi-Aventis Deutschland GmbH, Therapeutic Area Immunology, Cytokine Modulation, Industriepark Hoechst, Building H821, Room 525, D-65926 Frankfurt am Main Germany, Tel: +49 69 305 17403; Fax: +49 69 305 47223; E-mail: Klaus.Flechsenhar@sanofi.com

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Journal of arthritis

自引率

0.00%

发文量